During a search for inhibitors of squalene synthase, a group of novel, highly active compounds, the squalestatins, was isolated from Phomasp. C2932ls2). Biosynthesis studies using 13C and 18O-labelled precursors showed that the backbone of the major squalestatin (1) was derived from two acetate-generated polyketide chains, a 4-carbon unit related to succinate, methionine and atmospheric oxygen3). Interestingly, the starter unit for one of the polyketide chains appeared to be benzoic acid, itself derived from phenylalanine. In an attempt to generate novel squalestatins, analogues of this aromatic starter unit were fed to Phomafermentations. This paper reports these feeding experiments and describes the analogues thus generated.
Materials and Methods

Organi sm
The squalestatin producer Phoma sp. C2932 was used for all of the work discussed.
Culture Conditions Phoma sp. C2932 was maintained as frozen (-70°C) spore suspensions in 5% (w/v) glycerol. To prepare working stocks, a spore suspension was thawed at room temperature and 0.5 ml was used to inoculate a seed culture dispensed as a 50 ml aliquot in a 250-ml Erlenmeyer flask. The seed medium had the following composition: peptone (Oxoid L34) 10g, malt extract (Oxoid L39) 21 g, glycerol 40g, Rj  R2  R3  R4   1  H  H  H  H  2  H  H  F  H  3  H  F  H  H  4  F  H  H  H  5  H  F  F  H  6  H  F  H  F  7  F  F  H  H SEPT. 1993 pH of the medium was adjusted to 6.5 by the addition of aqueous NaOHprior to autoclaving. The flask of inoculated seed mediumwas then incubated at 25°C on an orbital shaker platform, rotating at 250rpm with a 50mmthrow, for 4 days. The culture was then dispensed through a sterile 20-ml plastic syringe to reduce clumping and stored in 1.8 ml aliquots at -20°C. For shake flask fermentations, 0.5 ml of the thawed culture (room temperature) was used to inoculate 50ml of the seed medium(dispensed in a 250-ml Erlenmeyer flask and prepared as above). Incubation conditions were as above except that cultures were incubated for 3 days as this was found to be optimal. 1 ml of the seed stage was transferred to the fermentation medium (2% (v/v)) dispensed as 50ml aliquots in 250-ml Erlenmeyer flasks. The fermentation mediumhad the following composition: cotton seed flour (Sigma) 20g, fructose 50g and soya bean oil 30g in 1 litre of distilled water. No pH adjustment of this medium was found to be necessary. Flasks were incubated at 25°C and agitated as above.
Feeding Experiments
Potential precursors of squalestatin analogues were routinely added to the fermentation stage after incubation for 3 days. Wherethe required feed was a solid at room temperature, an aqueous solution was prepared (6.25 mg/ml), adjusted to neutral pH with NaOHand filter sterilised. 2ml of each precursor was then added to 50ml of the fermentation mediumto give a final concentration of 250jug/ml. Flasks were harvested following a 7 day fermentation (4 days post feeding).
Radioactive Labelling and Analysis 7-[14C]-Benzoic acid (16 mCi/mmol, 20 /iCi/50 ml culture, Amersham International) was added to a 3 day culture of C2932 in fermentation medium (50 ml in a 250-ml flask). 1 ml samples were removed daily and mixed with an equal volume of MeCNcontaining H2SO4(5ml/litre). The sample was then shaken and left to stand for 30 minutes. The sample was centrifuged at 10,000 x g for 10 minutes and the supernatant was decanted into a fresh tube. The sample was then centrifuged again and 200[A of supernatant was chromatographed using the gradient HPLCsystem. 45 fractions (0.67 ml) were collected over 30 minutes and 10ml of Optiphase Safe scintillation fluid (LKB) was added to each fraction. Radioactivity was determined by scintillation counting with a 14C programme.
HPLCAnalysis
Samples were prepared for HPLCanalysis by mixing whole broth with an equal volume of MeCN containing H2SO4(5 ml/litre). Supernatant was removed after centrifugation at 1,200 x g for 30 minutes. Samples were injected onto a Spherisorb C6 5 /xm column (15 cm x 4.6mm i.d.) which was developed with a gradient of0~50% MeCNin water containing H2SO4 (50^I/litre) (flow rate: 1 ml/minute) with monitoring at210nm.
HPLC-MS Analysis
Samples were prepared for HPLC-MS analysis by mixing whole broth with an equal volume of MeCN containing TFA(5 ml/litre). The samples were centrifuged at 1,200 x g for 30 minutes and the supernatant collected.
Aliquots of the supernatant were injected onto a Spherisorb S5 ODS-2 HPLC column (25cmx2mm) and the components of interest were eluted with MeCN-H2O(55:45) (flow rate: 0.5 ml/minute) containing 0. 1 % TFA (v/v). The HPLCsystem was connected via a thermospray interface (TSP2) to a Finnigan Mat TSQ70B mass spectrometer. The thermospray conditions were optimised to: source temperature 250°C, vapouriser temperature 70°C, repeller voltage-10V, mode negative ion TSP filament on, filament emission current 600 juA, conversion dynode voltage-20,000V. Under these LCconditions 1 and its fluorinated analogues co-eluted, but from the mass spectra it was possible to differentiate between the two compounds.
Product Isolation
The crude broths were treated in one of two ways. In the first method the cells were extracted twice with water adjusted to pH 10.4 with ammoniasolution, and after removal of the cells by centrifugation the pooled supernatants were adjusted to pH 8.2. Alternatively, one volume of MeCNcontaining H2SO4 (150^I/litre) was added to the broth and the cells were harvested by centrifugation and re-extracted with MeCN-H2O(1 : 1). The extracts were pooled, and the MeCNwas removed under vacuum. Extracts that were oily were filtered through a cellulose bed. Compounds of interest were then adsorbed onto an Amberlite XAD-16column. The column was washed successively with water, 1% tetrasodium EDTA(w/v) and water, and then elution was carried out with Me2CO-H2O(6 : 4). Fractions containing 1 and its analogues were pooled, diluted and acidified with H2SO4 and then loaded onto a Spherisorb S5 ODS-2 HPLC column (25 x2.1cm). The column was washed with MeCN-H2O(25:75)+H2SO4 (2ml/litre) and compounds were eluted with MeCN-H2O(1 : 1)+H2SO4(2ml/litre).
The resulting fractions contained only 1 and analogues. These fractions were concentrated under vacuum.
Compounds 2 and 3 were separated from 1 by preparative HPLCusing a Spherisorb S5 ODS-2 column (25 x 2.1 cm) and a mobile phase of MeCN-H2O(45 : 55)+H2SO4 (2ml/litre).
Compounds 4 and 1 were resolved on a Spherisorb C6 column (25 x2.1cm) using a mobile phase of MeOH-H2O (57.5:42.5) adjusted to pH 3 using H3PO4. Substituted benzoic acids (250mg/litre) were added to a 3 day flask culture of C2932. Each culture was examined by HPLCand HPLC-MS to determine whether the substituted benzoic acid had been incorporated into an analogue of 1. The column labelled 'utilisation' refers to an HPLCdetermination of substituted benzoic acid utilisation between time of addition (day 3) and harvest (day 7). The analogues which were isolated were tested in the mammaliansqualene synthase (S.QS) and the Candida squalene synthase (CSS) assays. The ranges of values that have been obtained for 1 are shown for comparison. Compounds5, 6 and 7 were not isolated for testing because they were only produced in scant amounts. In (A) the three principal ions from compound1 are shown. These are also present in (B) because in this HPLCsystem, 1 and its monofluorinated analogues cb-eluted. In (B) and (C) the associated ions shifted up by 18 and 36 mass units respectively, are shown, indicating that the monofluoro-and difluoro-compounds had been successfully incorporated into analogues of 1. The (M -H) ion of 6 (C) was not observed.
Biological Testing
Inhibition of squalene synthase (rat and Candida albicans) was determined as described previously1*.
Results and Discussion
Incorporation of 7-[14C]-Benzoic Acid Into 1 Confirmation that benzoic acid could be incorporated into 1 was obtained by feeding 7-[14C]-labelled material to a growing culture of C2932. If the benzoic acid was added at the time of inoculation, no incorporation was observed, but if the addition was made at day 3,4 or 5 (corresponding to the maximum rate of synthesis of 1) then incorporation at a level of 7%was observed (Fig. 2) . All additions for subsequent experiments were madeat day 3.
Generation of Squalestatin Analogues Feeding experiments were carried out using a broad range of substituted benzoic acid compounds (Table 1) . Of those tested, the monofluorobenzoic acids showed good incorporation and two of the 400 -700  85  152  132  88  122  180  108  146  133  164  188  143  150  86  292  131  100  49  211  241  156  142  189  138  143  60  61   4   3 . SEPT. 1993 difluoro-compounds showed low levels of incorporation. The squalestatin analogues generated are shown in Fig. 1 . Of the six analogues generated, only 2, 3 and 4 were isolated in sufficient quantities for NMRspectroscopy and biological testing. These three analogues appeared to be marginally less active than 1 against mammaliansqualene synthase and 2 and 4 were slightly less active than 1 against the fungal enzyme (Table 2) . Clearly, the incorporation of a fluorine atom in the aromatic ring did not have a dramatic effect on the biological activity. The structures of the monofluorinated squalestatins were determined by HPLC-MS (Fig. 3) and *H NMR (Table 3 ) and by comparison with spectroscopic data obtained from 12). The* structure of the difluorinated squalestatins was indicated by HPLC-MS. In addition to the mass spectrometry described, accurate mass negative ion Fast Atom Bombardment with polyethylene glycol calibration ions, was performed on the molecular ion ((M -H)~) of purified 4. This showed an error of only 1.7ppm from the calculated value. The XHNMRassignments of aromatic protons of compounds 1~4 are shown in Table  3 and all other XHNMRresonances of compounds 2~4 are similar to those of 1. In addition to *H NMR,a 19F NMRspectrum of 2 was recorded at 376MHzon a Varian VXR400spectrometer, in MeOD-^solution, at 303 K. The couplings observed (-1 18.75 ppm, (tt, 8,5 Hz)) are consistent with those in the proton spectrum.
There was no evidence of incorporation of any of the other substituted benzoic acids although a number appeared to be completely metabolised by the microorganism (C2923). In most cases, addition of the benzoic acid analogue reduced the production of 1. The reason that the mono-and difluorinated benzoates were incorporated may partly have been that the hydrogen and fluorine atoms are nearly isosteric4>5). It is not clear whether the failure to detect even low levels of incorporation of the other compoundswas due to enzymespecificity or to the failure of uptake of these compounds.
There are several possible biosynthetic routes leading to the formation of benzoic acid prior to incorporation into 16). Consequently, substituted phenylalanine, cinnamic acid and benzaldehyde compounds were also tested for incorporation intp analogues of 1. As indicated in Table 4 , all the monofluorinated derivatives of these compoundswere found to be incorporated, as well as one of the difluorinated benzaldehydes. This suggested that the supply pathway for benzoic acid was from phenylalanine via cinnamic acid (i.e. via the phenylalanine ammonialyase pathway)7). The incorporation of fluorinated benzaldehyde could also suggest that this was part of the 'feeder' pathway, but a simple chemical oxidation to the benzoic acid could not be excluded. 
